Vorapaxar: The missing link in antiplatelet therapy!

Vorapaxar: The missing link in antiplatelet therapy!

Bibliographic Details
Main Author:	Abhijit S Nair
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Journal of Anaesthesiology Clinical Pharmacology
Online Access:	http://www.joacp.org/article.asp?issn=0970-9185;year=2017;volume=33;issue=2;spage=269;epage=270;aulast=Nair

Similar Items

Vorapaxar
by: Gianluca Airoldi, et al.
Published: (2013-04-01)

Vorapaxar as an Alternative for Ticagrelor Resistance in Neuroendovascular Intervention
by: James C. Mamaril‐Davis, et al.
Published: (2021-11-01)

Abstract 1122‐000043: Vorapaxar as An Alternative for Ticagrelor Resistance in Neuroendovascular Intervention
by: James C Mamaril‐Davis, et al.
Published: (2021-11-01)

Clinical use of vorapaxar as an emerging antithrombin agent: A literature review of current evidence
by: Farjah H Algahtani
Published: (2017-01-01)

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation
by: Julian Friebel, et al.
Published: (2021-12-01)

Trials of antiplatelet therapy.
by: Bounameaux, H
Published: (1994)

Antiplatelet Therapy Considerations in Women
by: Khadeeja Esmail, et al.
Published: (2019-01-01)

TRIALS OF ANTIPLATELET THERAPY - REPLY
by: Baigent, C, et al.
Published: (1994)

DURATION OF DUAL ANTIPLATELET THERAPY
by: O. L. Barbarash
Published: (2016-07-01)

The Missing Link
by: Patrick Jaojoco
Published: (2023-11-01)

The Missing Link
by: Patrick Jaojoco
Published: (2023-11-01)

Missing link
by: Hans Rooseboom
Published: (2023-10-01)

Antiplatelet therapy in acute cerebral ischaemia.
by: Sandercock, P, et al.
Published: (1999)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
by: Patrono, C, et al.
Published: (2010)

COVID-19 and the Response to Antiplatelet Therapy
by: Tomáš Bolek, et al.
Published: (2023-03-01)

Antiplatelet Therapy in Acute Coronary Syndrome
by: I. M. Kuzmina, et al.
Published: (2022-01-01)

ANTIPLATELET THERAPY IN THE PREVENTION OF CEREBROVASCULAR ACCIDENTS
by: O. V. Rodionova, et al.
Published: (2017-03-01)

Antiplatelet therapy strategies for ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2017-07-01)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
by: Giulia Magnani, et al.
Published: (2023-08-01)

Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
by: Yuji Shimada, et al.
Published: (2022-09-01)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
by: Marie Muthspiel, et al.
Published: (2022-11-01)

ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY
by: E. А. Ushkalova, et al.
Published: (2017-03-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Antiplatelet Therapy for Acute Respiratory Distress Syndrome
by: Chuan-Mu Chen, et al.
Published: (2020-07-01)

Sex differences in antiplatelet therapy: state-of-the art
by: Aleksandra Gasecka, et al.
Published: (2023-12-01)

Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy
by: GianMarco Podda, et al.
Published: (2018-10-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Antiplatelet therapy for Staphylococcus aureus bacteremia: Will it stick?
by: Alexander M Tatara, et al.
Published: (2022-02-01)

Antiplatelet therapy in secondary prevention of ischemic stroke
by: V. A. Parfyonov, et al.
Published: (2015-12-01)

TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
by: O. L. Barbarash, et al.
Published: (2016-02-01)

The missing link in internationalisation
by: Jos Beelen
Published: (2017-12-01)

Finding the missing link
by: Schwartz, Thomas
Published: (2014)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
by: Collins, R, et al.
Published: (1994)

Expanding the horizons of antiplatelet therapy. A pilot study of the antiplatelet properties of a new tropane alkaloid
by: Ruben S. Mirzoian, et al.
Published: (2020-09-01)

Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA‐PRATIC Study
by: Francesco Franchi, et al.
Published: (2020-04-01)

Ever decreasing circles: advances in antiplatelet therapy and anticoagulation.
by: Kennedy, J, et al.
Published: (2003)

Anticoagulant and antiplatelet therapy for chronic kidney disease patients
by: I. Dudar, et al.
Published: (2019-12-01)

Dual Antiplatelet Therapy: A Concise Review for Clinicians
by: Hafeez Ul Hassan Virk, et al.
Published: (2023-07-01)

Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
by: Tsuguru Hayashi, et al.
Published: (2020-10-01)